Botanical species · safety record
Ptychopetalum olacoides
The EFSA Compendium of Botanicals holds 5 constituent measurements for Ptychopetalum olacoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Ptychopetalum olacoides Benth.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 125 licensed products naming Ptychopetalum olacoides as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- 3,4-dihydroxybenzoic acid1
- Camphor1
- Clerodane-type diterpenes1
- Eugenol1
- Theobromine1
Plant parts
- Bark3
- Roots and other underground parts2
Preparations
- Solvent extraction4
- Essential oil1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| 3,4-dihydroxybenzoic acid | Bark | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Theobromine | Bark | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Camphor | Roots and other underground parts | Essential oil | 6.2 Percent | GC-MS | No resolvable identifier |
| Clerodane-type diterpenes | Bark | Solvent extraction | — | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| Eugenol | Roots and other underground parts | Solvent extraction | — | GC-MS (Q) | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Ito, Yuji., Hirayama, Fusayoshi., Aikawa, Yoko., Kondo, Hideaki., Sagara, Kazuhiko., Shoji, Junzo. Constituents from Muira-puama (the roots of Ptychopetalum olacoides).. Natural Medicines, 1995.
- Bucek, E. Uber., Fournier, G., Dadoun, H. Volatile constituents of Ptychopetalum olacoides root oil. Planta Medica, 1987.
- Tang, Wanxia., Harada, Kenichi., Kubo, Miwa., Hioki, Hideaki., Fukuyama, Yoshiyasu. Eight New Clerodane Diterpenoids from the Bark of Ptychopetalum olacoides . Natural product communications, 2011, vol. 6, no. 3, p. 327-332.
- Colombo, Renata., Batista, Andrea N. de L., Bomfim, Giovani C. C., Burgos, Rosilene C. R., Cavalheiro, Alberto J., Bolzani, Vanderlan da Silva., Silva, Dulce Helena S., Reimberg, Maria Celia H. Validated high-performance liquid chromatographic method for the standardisation of Ptychopetalum olacoides Benth., Olacaceae, commercial extracts. REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2010, vol. 20, no. 5, p. 781-788. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.